Arquivo · News · 2018-04-25
Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism – a source of biomarkers for clinical diagnosis.
https://molecularautism.biomedcentral.com/track/pdf/10.1186/s13229-017-0183-3
The aim of this study was to explore the diagnostic utility of proteotoxic biomarkers in plasma and urine, plasma protein glycation, oxidation, and nitration adducts, and related glycated, oxidized, and nitrated amino acids (free adducts), for the clinical diagnosis of ASD.
Desarrollan nuevas pruebas de sangre y orina para diagnosticar autismo en niños
